duloxetine hydrochloride has been researched along with epothilone a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chu, SH; Cleeland, CS; Geng, Y; Lee, ES; Lee, YJ; Wang, XS | 1 |
Alberti, P; Argyriou, AA; Demichelis, C; Park, SB; Schenone, A; Tamburin, S | 1 |
2 review(s) available for duloxetine hydrochloride and epothilone a
Article | Year |
---|---|
Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
Topics: Amitriptyline; Anticonvulsants; Antidepressive Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Carbamazepine; Central Nervous System; Cyclohexanols; Duloxetine Hydrochloride; Epothilones; Humans; Neoplasms; Neuralgia; Oxcarbazepine; Peripheral Nervous System Diseases; Pyrazines; Taxoids; Thalidomide; Thiophenes; Venlafaxine Hydrochloride; Vinca Alkaloids | 2015 |
Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
Topics: Antineoplastic Agents; Bridged-Ring Compounds; Clinical Trials as Topic; Duloxetine Hydrochloride; Epothilones; Humans; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Prospective Studies; Serotonin and Noradrenaline Reuptake Inhibitors; Taxoids; Treatment Outcome; Tubulin Modulators | 2019 |